InsidersTradesSigma
Follow the Jubilant Pharmova stock price and the full management transaction log of the company, a listed issuer based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Market capitalisation: €139.3bn. The latest transaction was reported on 30 June 2026 (Pledge). Among the most active insiders: HSB Trustee Company Private Ltd and HS Trustee Company Pvt Ltd. The full history is free.
Analysts rate Jubilant Pharmova Buy (bullish), based on 2 analysts. Average price target: ₹1,088.50.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Jubilant Pharmova 是一家专注于药品生产和医疗保健服务的制药公司。该公司在孟买证券交易所上市，股票代码为 XBOM。